Intelligence · Clinical Development
Pipeline search results
Programs matching “epithelial” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 43 pipeline programs matching "epithelial" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
[68Ga]BED003 injection
Blue Earth Diagnostics Ireland Ltd
Colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), invasive lobular breast cancer (ILC), and epithelial ovarian cancer (EOC).
1 trial -
entinostat
Syndax Pharmaceuticals
Epithelial Ovarian Cancer
1 trial -
950P1V02
Toray International U.K. Limited
Bladder cancer, Cholangiocarcinoma, Colorectal Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Gastric Cancer, Melanoma, Ovarian Cancer, Palpable Subcutaneous Malignant Lesions, Primary Peritoneal Cancer, Renal Cell Carcinoma, Solid Tumor
1 trial -
CKFA115A12101
Novartis Pharmaceuticals
Thymic Carcinoma, Nasopharyngeal Cancer, Anal Cancer, Head and Neck Squamous Cell Carcinoma, Epithelial Ovarian Cancer, Cutaneous melanoma, Mesothelioma, Non-small cell lung cancer, Esophagogastric Cancer, Triple negative breast cancer, Microsatellite Instability High Colorectal Cancer, Clear Cell Renal Cell Carcinoma
1 trial -
Cemiplimab
Regeneron UK Limited
Epithelial Ovarian Cancer
1 trial -
Debio 0123-102
Alphapharm Pty Ltd
Arm A: Diagnosed with uterine serous carcinoma (USC) Arm B: Diagnosed with recurrent or progressive, high-grade epithelial ovarian cancer (EOC) with cyclin E1-driven selection Arm C: Diagnosed with solid tumor with biomarker-driven selection
1 trial -
Human Amniotic Epithelial Stem Cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Parkinson's Disease
1 trial -
Human amniotic epithelial stem cells（hAESCs）
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Graft Versus Host Disease
1 trial -
LCAR-M23 cells
Nanjing Legend Biotech Co.
Epithelial Ovarian Cancer
1 trial -
NX-1607
Nurix Therapeutics
Ovarian Cancer, Epithelial
1 trial -
STRO-002-GM2
SUTRO BIOPHARMA, INC.
Advanced Epithelial Ovarian Cancer (including Fallopian Tube or Primary Peritoneal cancers)
1 trial -
VHIO20001
The George Institute
Advanced epithelial tumors and immune checkpoint blockade (ICB) resistant solid tumors
1 trial -
[18F]fluoro-PEG-folate PET/CT scan
BRIGHT MINDS BIOSCIENCES INC.
Epithelial Ovarian Cancer
1 trial -
Aflibercept
Regeneron UK Limited
Submacular Vascularized Pigment Epithelial Detachments
1 trial -
Aflibercept
Regeneron UK Limited
Fibrovascular Pigment Epithelial Detachment
1 trial -
Niraparib
Takeda
Epithelial Ovarian Cancer
1 trial -
SINECATECHINS
The George Institute
Anal high-grade squamous intraepithelial lesions (HSIL).
1 trial -
Sodium Chloride 0.9% for Vulvar High-Grade Squamous Intr…
Disc Medicine
Vulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)
1 trial -
Daphne Extract Capsules
The First People's Hospital of Lianyungang
Epithelial Ovarian Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.